These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6609195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
    Falkenburg JH, van der Vaart-Duinkerken N, Veenhof WF, Goselink HM, van Eeden G, Parlevliet J, Jansen J.
    Exp Hematol; 1984 Dec; 12(11):817-21. PubMed ID: 6210206
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective expression of class-II MHC antigens during hemopoietic differentiation.
    Katz FE, Davis L, Myers CD, Greaves MF.
    Exp Hematol; 1985 Dec; 13(11):1182-7. PubMed ID: 3864642
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.
    Ottmann OG, Nocka KH, Moore MA, Pelus LM.
    Leukemia; 1988 Oct; 2(10):677-86. PubMed ID: 3172844
    [Abstract] [Full Text] [Related]

  • 8. Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.
    Falkenburg JH, Fibbe WE, Veenhof WF, Koning F, van Eeden G, Voogt PJ, Jansen J.
    Exp Hematol; 1986 Feb; 14(2):101-7. PubMed ID: 2417877
    [Abstract] [Full Text] [Related]

  • 9. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
    Aglietta M, Piacibello W, Stacchini A, Dezza L, Sanavio F, Malavasi F, Infelise V, Resegotti L, Gavosto F.
    Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Different Ia antigen characterization between granulocyte progenitor cells (CFC-G) and monocyte-macrophage progenitor cells (CFC-M).
    Numata M, Koizumi S, Horita S, Ueno Y, Yamagami M, Taniguchi N.
    Exp Hematol; 1985 Sep; 13(8):827-32. PubMed ID: 3862598
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies to HLA-A,B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells.
    Fitchen JH, Ferrone S, Quaranta V, Molinaro GA, Cline MJ.
    J Immunol; 1980 Nov; 125(5):2004-8. PubMed ID: 6159398
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.
    Snoeck HW, Lardon F, Lenjou M, Nys G, Van Bockstaele DR, Peetermans ME.
    Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636
    [Abstract] [Full Text] [Related]

  • 17. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
    Dowding CR, Gordon MY, Goldman JM.
    Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
    [Abstract] [Full Text] [Related]

  • 18. Studies on the use of nonhuman primates to determine the DR status of the human hematopoietic stem cell.
    Winton EF, Colenda KW, McClure HM, Chan WC, Gordon DS.
    Exp Hematol; 1985 Oct; 13(9):869-73. PubMed ID: 3862599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.